Havas Life Mumbai & Shobiz Redefine Healthcare Experiential Engagement

Introduction

What happens when deep medical intelligence meets world-class experiential design? You get a partnership that could fundamentally change how India's pharmaceutical and healthcare brands connect with doctors, patients, and caregivers alike.

India's healthcare communications sector is at a decisive turning point. Scientific breakthroughs are outpacing the industry's ability to communicate them meaningfully. Traditional CME events, detailing aids, and static digital campaigns are no longer enough. The market is demanding something far more compelling — and measurable. That's where this alliance steps in.

The Big Announcement

Havas Life Mumbai, the healthcare communications agency under Havas India, and Shobiz, Havas India's experiential design and execution agency, have formally announced a strategic collaboration to build fully integrated, end-to-end experiential engagement solutions for India's healthcare and pharmaceutical sector.

The move addresses a challenge that has quietly frustrated the industry for years — a structural disconnect between agencies with strong scientific depth and those with large-scale event and experience execution muscle. Most brands have had to juggle multiple partners to get both. This partnership collapses that gap into a single, unified offering.

The combined capability will span immersive technologies including Virtual Reality (VR), Augmented Reality (AR), Mixed Reality (MR) simulations, AI-powered interactive tools, and data-driven engagement platforms — all designed to be medically compliant, outcome-focused, and scalable across HCP (Healthcare Professional), patient, and caregiver audiences.

What This Means for Your Brand

For pharma brand managers and medical affairs teams in India, this partnership signals a meaningful shift in what "engagement" can look like.

Consider a pharmaceutical brand launching a complex oncology drug. Traditionally, this would involve printed detailing literature, a medical rep pitch, and perhaps a regional CME. Now, imagine instead an immersive VR simulation that lets an oncologist experience the drug's mechanism of action at a cellular level — followed by a data dashboard that tracks engagement depth and retention. That's the kind of differentiated, measurable experience this alliance is built to deliver.

Similarly, for patient awareness campaigns — especially in chronic care categories like diabetes, cardiovascular health, or rare diseases — the combination of Havas Life Mumbai's scientific credibility and Shobiz's large-format experience design opens doors to campaigns that genuinely educate, rather than simply inform.

Here's the contrarian take worth considering: not every brand needs a VR setup at their next product launch. The real opportunity in this partnership is the integrated compliance-plus-creativity framework — something India's pharma sector has historically struggled to balance. That's the deeper value on offer here.

Expert Take

India's healthcare advertising and communications market is expanding rapidly alongside the broader pharma sector, which is projected to reach USD 130 billion by 2030, according to industry estimates. Yet, investment in experiential healthcare engagement has remained disproportionately low compared to global benchmarks.

Globally, pharma brands that invest in immersive, experience-led engagement report higher HCP recall rates and stronger long-term brand associations compared to conventional detailing approaches — a gap that becomes especially critical when launching differentiated molecules or biologics in competitive therapeutic categories.

Dorelle Kulkarni, Managing Director of Havas Life Mumbai, captures the intent well: healthcare brands today require experiences that simplify complex science, inspire action, and build lasting trust — not just communication outputs. Sameer Tobaccowala, CEO of Shobiz, reinforces this by pointing to the intersection of scientific credibility and immersive experience design as the frontier where the industry must now operate.

The brands.in Perspective

India's pharma and healthcare marketing ecosystem has long operated in silos — medical affairs on one side, brand experiential on the other, compliance hovering nervously in the middle. This Havas Life Mumbai–Shobiz alliance is a direct challenge to that fragmented model.

What makes it genuinely interesting is not the technology stack — VR and AR have been discussed in healthcare marketing circles for years. It's the organisational intent: a single, accountable partner that speaks both the language of regulatory compliance and large-scale immersive storytelling. If executed well, this could set the benchmark for integrated healthcare engagement in India.

Key Takeaways for Marketers

• Havas Life Mumbai and Shobiz unite under Havas India for pharma engagement
• Partnership targets HCPs, patients, and caregivers with science-led experiences
• Immersive tech: VR, AR, MR, AI tools, and data platforms are core offerings
• Addresses India's long-standing gap between medical depth and experiential scale
• Positions integrated, compliant experiential delivery as the new industry standard

FAQ Section

Q1. What is the Havas Life Mumbai and Shobiz partnership about? It's a strategic collaboration between two Havas India agencies — one specialising in healthcare communications, the other in experiential design — to deliver integrated, technology-driven engagement solutions for pharma and healthcare brands in India.

Q2. How will this partnership benefit pharmaceutical brands in India? Brands gain a single partner capable of combining scientific rigour with immersive experience design — from VR-led HCP engagement to compliant, large-scale patient awareness activations — all measurable and outcome-driven.

Q3. What technologies will the collaboration leverage? The partnership will deploy VR, AR, and Mixed Reality simulations, AI-powered interactive tools, and data-driven engagement platforms tailored for healthcare and pharma compliance requirements.

Closing CTA

Does your healthcare brand still rely on traditional detailing and static CMEs to engage doctors and patients? The rules of engagement are changing fast — and the brands that adapt now will own the trust advantage tomorrow.

Follow brands.in for daily intelligence on how India's boldest brands are reshaping marketing, media, and communications. Drop your thoughts in the comments — we'd love to know: is experiential the future of pharma marketing in India, or is there still a case for the old playbook?